Inclusion of Rituximab in Treatment Protocols for Non-Hodgkin's Lymphomas and Risk for Progressive Multifocal Leukoencephalopathy

被引：38

作者：

Tuccori, Marco ^{[1
]}

Focosi, Daniele ^{[2
]}

Blandizzi, Corrado ^{[1
,5
]}

Pelosini, Matteo ^{[2
]}

Montagnani, Sabrina ^{[1
,5
]}

Maggi, Fabrizio ^{[3
,4
]}

Pistello, Mauro ^{[3
,4
]}

Antonioli, Luca ^{[1
]}

Fornai, Matteo ^{[1
]}

Pepe, Pasquale ^{[6
]}

Rossi, Giuseppe ^{[6
]}

Petrini, Mario ^{[2
]}

机构：

[1] Univ Pisa, Dept Internal Med, Div Pharmacol & Chemotherapy, Pisa, Italy

[2] Univ Pisa, Div Haematol, Dept Oncol Transplantat & New Technol Med, Pisa, Italy

[3] Univ Pisa, Virol Sect, Pisa, Italy

[4] Univ Pisa, Retrovirus Ctr, Dept Expt Pathol, Pisa, Italy

[5] Tuscan Reg Ctr Pharmacovigilance, Pisa, Italy

[6] CNR, Unit Epidemiol & Biostat, Inst Clin Physiol, Pisa, Italy

来源：

ONCOLOGIST | 2010年 / 15卷 / 11期

关键词：

Rituximab; Progressive multifocal leukoencephalopathy; JCV; Monoclonal antibody; Non-Hodgkin's lymphoma; ADVERSE DRUG EVENTS; NATALIZUMAB; EFALIZUMAB; THERAPY; PROJECT; DISEASE; PML;

D O I：

10.1634/theoncologist.2010-0098

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Objectives. Rituximab is an anti-CD20 monoclonal antibody that promotes better treatment outcomes in patients with non-Hodgkin's lymphoma (NHL). Case series of progressive multifocal leukoencephalopathy (PML) in patients receiving rituximab within polychemotherapy regimens have led to the introduction of a black box warning, but no risk estimation has ever been provided. Methods. We performed a retrospective, monocentric cohort study on 976 NHL patients diagnosed in 1994-2008, including 517 patients who received at least one dose of rituximab. Results. Inclusion of rituximab into standard chemotherapy regimens for NHL caused a significantly higher incidence of PML cases (rate difference, 2.2 every 1,000 patient-years; 95% confidence interval, 0.1-4.3). Interpretation. Based on this finding, clinical surveillance of PML-related symptoms is recommended in NHL patients exposed to rituximab. The Oncologist 2010;15:1214-1219

引用

页码：1214 / 1219

页数：6

共 50 条

[41] Progressive Multifocal Leukoencephalopathy in an HIV-Negative Patient following Treatment with Rituximab [J].

Khoury, Shafik ;

Shapira, Shirley ;

Zilberman, Tal ;

Mekori, Yoseph A. ;

Hershko, Alon Y. .

ISRAEL MEDICAL ASSOCIATION JOURNAL, 2013, 15 (06) :321-322

[42] Cell-free circulating DNA in Hodgkin's and non-Hodgkin's lymphomas [J].

Hohaus, S. ;

Giachelia, M. ;

Massini, G. ;

Mansueto, G. ;

Vannata, B. ;

Bozzoli, V. ;

Criscuolo, M. ;

D'Alo, F. ;

Martini, M. ;

Larocca, L. M. ;

Voso, M. T. ;

Leone, G. .

ANNALS OF ONCOLOGY, 2009, 20 (08) :1408-1413

[43] Physician Experience and Risk of Rituximab Discontinuation in Older Adults With Non-Hodgkin's Lymphoma [J].

Huntington, Scott F. ;

Hoag, Jessica R. ;

Wang, Rong ;

Zeidan, Amer M. ;

Girl, Smith ;

Gore, Steven D. ;

Ma, Xiaomei ;

Gross, Cary P. ;

Davidoff, Amy J. .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2019, 17 (10) :1194-+

[44] Non-Hodgkin's lymphomas and occupation in Sweden [J].

Cano, MI ;

Pollán, M .

INTERNATIONAL ARCHIVES OF OCCUPATIONAL AND ENVIRONMENTAL HEALTH, 2001, 74 (06) :443-449

[45] Progressive Multifocal Leukoencephalopathy After Chimeric Antigen Receptor T-Cell Therapy for Recurrent Non-Hodgkin Lymphoma [J].

Ahrendsen, Jared T. ;

Sehgal, Kartik ;

Sarangi, Sasmit ;

Uhlmann, Erik J. ;

Varma, Hemant ;

Arnason, Jon ;

Avigan, David .

JOURNAL OF HEMATOLOGY, 2021, 10 (05) :212-216

[46] Autoimmune thrombocytopenia in non-Hodgkin's lymphomas [J].

Hauswirth, Alexander W. ;

Skrabs, Cathrin ;

Schuetzinger, Christian ;

Raderer, Markus ;

Chott, Andreas ;

Valent, Peter ;

Lechner, Klaus ;

Jaeger, Ulrich .

HAEMATOLOGICA, 2008, 93 (03) :447-450

[47] Immunotherapy of malignant non-Hodgkin's lymphomas [J].

Heß G. .

Der Onkologe, 2005, 11 (5) :571-577

[48] Radioimmunotherapy strategies for non-Hodgkin's lymphomas [J].

Corcoran, MC ;

Eary, J ;

Bernstein, I ;

Press, OW .

ANNALS OF ONCOLOGY, 1997, 8 :133-138

[49] Non-Hodgkin's Lymphomas, Version 2.2014 [J].

Zelenetz, Andrew D. ;

Gordon, Leo I. ;

Wierda, William G. ;

Abramson, Jeremy S. ;

Advani, Ranjana H. ;

Andreadis, C. Babis ;

Bartlett, Nancy ;

Bellam, Naresh ;

Byrd, John C. ;

Czuczman, Myron S. ;

Fayad, Luis E. ;

Fisher, Richard I. ;

Glenn, Martha J. ;

Harris, Nancy Lee ;

Hoppe, Richard T. ;

Horwitz, Steven M. ;

Kelsey, Christopher R. ;

Kim, Youn H. ;

Krivacic, Susan ;

LaCasce, Ann S. ;

Nademanee, Auayporn ;

Porcu, Pierluigi ;

Press, Oliver ;

Rabinovitch, Rachel ;

Reddy, Nishitha ;

Reid, Erin ;

Sokol, Lubomir ;

Swinnen, Lode J. ;

Tsien, Christina ;

Vose, Julie M. ;

Yahalom, Joachim ;

Zafar, Nadeem ;

Dwyer, Mary ;

Sundar, Hema .

JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK, 2014, 12 (06) :916-945

[50] Immunophenotyping of Non-Hodgkin's lymphomas in Sudan [J].

Hamid, Khalid Hamad ;

Elduma, Adel Hussein ;

Mohamed, Badereldin Mirgani Yousif ;

Salih, Magdi Mansour Abdel Farage .

PAN AFRICAN MEDICAL JOURNAL, 2014, 18

← 1 2 3 4 5 →